A new and dynamic leader in developing a microbiome drug.
From Microbiome to Medicine
Finding links between disease and human microbiome
Microbiome Modulatory Novel Drugs and Functional Food Materials Development for treating diseases
By modulating the microbiome through a self-built screening platform for functional materials and metagenome analyses using NGS (next-generation genomic analysis technology), AtoGen Co., Ltd. is researching and developing new drugs and functional health food materials that can treat various diseases and improve health.
Research capacity construction for each research theme